Bortolotti, S.; Angelucci, S.; Montemurro, L.; Bartolucci, D.; Raieli, S.; Lampis, S.; Amadesi, C.; Scardovi, A.; Nieddu, G.; Cerisoli, L.;
et al. Antigene MYCN Silencing by BGA002 Inhibits SCLC Progression Blocking mTOR Pathway and Overcomes Multidrug Resistance. Cancers 2023, 15, 990.
https://doi.org/10.3390/cancers15030990
AMA Style
Bortolotti S, Angelucci S, Montemurro L, Bartolucci D, Raieli S, Lampis S, Amadesi C, Scardovi A, Nieddu G, Cerisoli L,
et al. Antigene MYCN Silencing by BGA002 Inhibits SCLC Progression Blocking mTOR Pathway and Overcomes Multidrug Resistance. Cancers. 2023; 15(3):990.
https://doi.org/10.3390/cancers15030990
Chicago/Turabian Style
Bortolotti, Sonia, Silvia Angelucci, Luca Montemurro, Damiano Bartolucci, Salvatore Raieli, Silvia Lampis, Camilla Amadesi, Annalisa Scardovi, Giammario Nieddu, Lucia Cerisoli,
and et al. 2023. "Antigene MYCN Silencing by BGA002 Inhibits SCLC Progression Blocking mTOR Pathway and Overcomes Multidrug Resistance" Cancers 15, no. 3: 990.
https://doi.org/10.3390/cancers15030990
APA Style
Bortolotti, S., Angelucci, S., Montemurro, L., Bartolucci, D., Raieli, S., Lampis, S., Amadesi, C., Scardovi, A., Nieddu, G., Cerisoli, L., Paganelli, F., Chiarini, F., Teti, G., Falconi, M., Pession, A., Hrelia, P., & Tonelli, R.
(2023). Antigene MYCN Silencing by BGA002 Inhibits SCLC Progression Blocking mTOR Pathway and Overcomes Multidrug Resistance. Cancers, 15(3), 990.
https://doi.org/10.3390/cancers15030990
